This week, six health care provider stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
Cross Country Healthcare, Inc.’s (CCRN) grade is moving up to a B (“buy”) this week from last week’s C (“hold”). Cross Country Healthcare provides healthcare staffing and outsourcing services to the healthcare market. In Portfolio Grader’s specific subcategories of Earnings Momentum, Earnings Surprise and Sales Growth, CCRN also gets A’s. Shares of the stock have been trading at an exceptionally rapid pace, up twofold from the week prior. For more information, get Portfolio Grader’s complete analysis of CCRN stock.
Triple-S Management Corporation Class B (GTS) boosts its rating from an A to a C this week. Triple-S Management is an independent licensee of the Blue Cross Blue Shield Association. For more information, get Portfolio Grader’s complete analysis of GTS stock.
Fresenius Medical Care AG & Co. KGaA Sponsored ADR (FMS) is seeing ratings go up from a C last week to a B this week. Fresenius Medical Care offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. For more information, get Portfolio Grader’s complete analysis of FMS stock.
This week, Bio-Reference Laboratories, Inc. (BRLI) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. Bio-Reference provides laboratory testing services, primarily to customers in the greater New York metropolitan area. For more information, get Portfolio Grader’s complete analysis of BRLI stock.
DaVita HealthCare Partners Inc. (DVA) improves from a C to a B rating this week. DaVita operates kidney dialysis centers in the United States. For more information, get Portfolio Grader’s complete analysis of DVA stock.
Sharps Compliance (SMED) earns an A this week, jumping up from last week’s grade of B. Sharps Compliance is a full-service provider of cost-effective solutions for management of medical waste and unused dispensed medications generated outside of the hospital and large health care facility setting, serving more than 4,000 customers in all 50 states. Shares of the stock have been trading at an exceptionally rapid pace, up 517.5% from the week prior. For more information, get Portfolio Grader’s complete analysis of SMED stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.